Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ana M. Saldaña-Cruz"'
Autor:
Juan A. Peraza-Zaldivar MD, Juan M. Ponce-Guarneros PhD, Ernesto G. Cardona-Muñoz PhD, Yussef Esparza-Guerrero PhD, Ana M. Saldaña-Cruz PhD, Sergio A. González-Vazquez MD, Laura Gonzalez-Lopez PhD, Jorge I. Gamez-Nava PhD, Norma A. Rodriguez-Jimenez PhD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 28 (2023)
Introduction Metabolic syndrome (MS) is associated with abnormalities in atrial mechanics, atrial remodeling, and an increased risk of heart rhythm disorders. One of the most commonly used approaches to the prevention of cardiac remodeling in arteria
Externí odkaz:
https://doaj.org/article/908ee5b363a94439ae34ec00a1110635
Autor:
Eli E. Gomez-Ramirez, Melissa Ramirez-Villafaña, Jorge I. Gamez-Nava, Fidencio Cons-Molina, Norma A. Rodriguez Jimenez, Ana M. Saldaña-Cruz, Ernesto G. Cardona-Muñoz, Sylvia E. Totsuka-Sutto, Juan M. Ponce-Guarneros, Xochitl Trujillo, Miguel Huerta, Alfonso J. Cruz-Jentoft, Laura Gonzalez-Lopez
Publikováno v:
Healthcare, Vol 10, Iss 10, p 2004 (2022)
Background: Muscle wasting, also known as myopenia, is frequent in rheumatoid arthritis (RA). To date, it is still unknown if the failure of pharmacologic therapies increases the risk of myopenia in RA. Objective: To identify if treatment failure wit
Externí odkaz:
https://doaj.org/article/9065f187a52d46af85d00073d9333586
Autor:
Melissa Ramirez-Villafaña, Ana M. Saldaña-Cruz, Javier A. Aceves-Aceves, Edsaul E. Perez-Guerrero, Nicté S. Fajardo-Robledo, Edy D. Rubio-Arellano, Cesar A. Nava-Valdivia, Maria O. Carrillo-Escalante, Sylvia E. Totsuka-Sutto, David Cardona-Müller, Betsabe Contreras-Haro, Mario Salazar-Paramo, Ernesto G. Cardona-Muñoz, M. Huerta, Jorge I. Gamez-Nava, Norma A. Rodriguez-Jimenez, Laura Gonzalez-Lopez
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
Background. Neuropeptide Y (NPY) is a sympathetic neurotransmitter with effects on the regulation of inflammatory cells. The role of NPY on autoimmune inflammatory diseases such as rheumatoid arthritis (RA) is not completely understood. Therefore, we
Externí odkaz:
https://doaj.org/article/2ed3a03221eb4ff781cc6938608d9796
Autor:
Fabiola Gonzalez-Ponce, Jorge I Gamez-Nava, Emilio E Perez-Guerrero, Ana M Saldaña-Cruz, Maria L Vazquez-Villegas, Juan M Ponce-Guarneros, Miguel Huerta, Xochitl Trujillo, Betsabe Contreras-Haro, Alberto D Rocha-Muñoz, Maria O Carrillo-Escalante, Esther N Sanchez-Rodriguez, Eli E Gomez-Ramirez, Cesar A Nava-Valdivia, Ernesto G Cardona-Muñoz, Laura Gonzalez-Lopez, Research Group for the Assessment of Prognosis Biomarkers in Autoimmune Disorders
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0255854 (2021)
BackgroundChemerin has a potential role in perpetuating inflammation in autoimmune diseases. Nevertheless, to date, there is no conclusive information on whether high chemerin levels increase the severity of rheumatoid arthritis (RA). Therefore, this
Externí odkaz:
https://doaj.org/article/20f724e9c1af410cbf6a1606d7a3dde3
Autor:
Edgar R. Valdivia-Tangarife, Jorge I. Gamez-Nava, Fernando. Cortés-Enríquez, Mario A. Mireles-Ramírez, Laura. Gonzalez-López, Ana M. Saldaña-Cruz, Miguel Angel. Macías-Islas
Publikováno v:
Multiple sclerosis and related disorders. 68
Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disease of the central nervous system. In NMOSD, a relapse results in increased disability.To assess risk factors associated with permanent disability (PD) in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393c7d6bddcb44d2d0839dde36be5125
https://pubmed.ncbi.nlm.nih.gov/36037753
https://pubmed.ncbi.nlm.nih.gov/36037753
Autor:
Melissa Ramirez-Villafaña, N Alejandra Rodriguez-Jimenez, Jorge I Gamez-Nava, Javier A Aceves-Aceves, Ana M Saldaña-Cruz, Ernesto G. Cardona-Muñoz, Sylvia E Totsuka-Sutto, J Manuel Ponce-Guarneros, Fidencio Cons-Molina, Xochitl Trujillo, Miguel Huerta, Alfonso J Cruz-Jentoft, Laura Gonzalez-Lopez
Background Low muscle mass (myopenia) is frequent in rheumatoid arthritis (RA) patients with a long-disease duration. Although, the use of combined therapy with conventional synthetic DMARDs (csDMARDs) is one of the main strategies observed in these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f2befad4c85690477a2fe7255e12be8
https://doi.org/10.21203/rs.3.rs-25713/v1
https://doi.org/10.21203/rs.3.rs-25713/v1
Autor:
Blanca E, Ríos-González, Karla E, Luévano-Ortega, Ana M, Saldaña-Cruz, Juan R, González-García, María Teresa, Magaña-Torres
Publikováno v:
Journal of genetics. 90(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b4f1ebe3eb8b3856a95c4780015aed79
https://pubmed.ncbi.nlm.nih.gov/22232194
https://pubmed.ncbi.nlm.nih.gov/22232194